(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-1.98% $ 1.235
Live Chart Being Loaded With Signals
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules...
Stats | |
---|---|
Dzisiejszy wolumen | 13 758.00 |
Średni wolumen | 137 349 |
Kapitalizacja rynkowa | 141.47M |
EPS | $0 ( 2024-03-01 ) |
Następna data zysków | ( $-0.150 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.930 |
ATR14 | $0.00500 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-05 | Vazquez Chris | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 7 392 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Strobeck Matthew | Buy | 1 304 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Schuler Jack W | Buy | 2 174 | Series A Non-Voting Convertible Preferred Stock |
2024-04-05 | Pestano Gary Anthony | Buy | 22 | Series A Non-Voting Convertible Preferred Stock |
INSIDER POWER |
---|
88.87 |
Last 100 transactions |
Buy: 13 131 293 | Sell: 601 205 |
Wolumen Korelacja
Biodesix, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
BNIXU | 0.898 |
HILS | 0.88 |
ENTA | 0.872 |
QNST | 0.861 |
FARO | 0.858 |
BNTX | 0.857 |
SBSI | 0.856 |
DYNT | 0.856 |
CZWI | 0.855 |
KPRX | 0.853 |
10 Najbardziej negatywne korelacje | |
---|---|
GPOR | -0.882 |
VRSK | -0.873 |
FTAA | -0.871 |
TBSAU | -0.868 |
NBSTU | -0.868 |
NVSA | -0.868 |
BLDR | -0.868 |
LGTO | -0.868 |
ITQ | -0.868 |
IRMD | -0.868 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biodesix, Inc. Korelacja - Waluta/Towar
Biodesix, Inc. Finanse
Annual | 2023 |
Przychody: | $49.09M |
Zysk brutto: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2023 |
Przychody: | $49.09M |
Zysk brutto: | $33.21M (67.66 %) |
EPS: | $-0.640 |
FY | 2022 |
Przychody: | $38.21M |
Zysk brutto: | $24.06M (62.96 %) |
EPS: | $-1.910 |
FY | 2021 |
Przychody: | $54.51M |
Zysk brutto: | $54.51M (100.00 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Biodesix, Inc.
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej